Syncom Formulations India informs about updates

03 Jan 2026 Evaluate
Syncom Formulations India has informed that it enclosed announcement in continuation of SYNCOM/SE/2025-26 dated 5th April, 2025 pursuant to Regulation 30 read with Schedule III Part A of SEBI (LODR) Regulations, 2015 for the demand raised under section 74(5) of CGST Act, 2017 for Ineligible Input Tax Credits also section 122 of CGST Act, 2017 for penalty.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

14.47 0.36 (2.55%)
02-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.35
Dr. Reddys Lab 1255.45
Cipla 1510.95
Zydus Lifesciences 916.50
Lupin 2105.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×